Institution
Format
Search results
-
News -
Press release Multiple myeloma: Early detection of aggressive tumors
Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients respond to treatment at first, the cancer comes back. To be able to intervene faster and on a more targeted basis, researchers at Charité – Universitätsmedizin Berlin, the Berlin Institute of Health at…
-
News QUEST Center QUEST Center as part of the Open Science Monitoring Initiative (OSMI)
The QUEST Center for Resposible Research recently became part of the Open Science Monitoring Initiative (OSMI).
-
GeneNovate Investors' Day
GeneNovate Investors' Day - Unlocking the Potential of Gene- and Cell-based Innovations © Sabine Gudath, Charité BIH Entrepreneurship Summit 2019 Gene and cell-based therapies (GCT) are one of the most important future topics for biomedical research and the clinical care of patients. The development of these therapies based on excellent research in…
-
News QUEST Center CERN-NASA Working Group "Incentives for Open Scholarship"
The 2023 CERN-NASA "Accelerating the Adoption of Open Science" Summit highlighted the need for concrete strategies to change research incentives towards open scholarship.
-
AG McCann: Advanced meta-analysis techniques for synthesizing data from animal studies
Advanced meta-analysis techniques for synthesizing data from animal studies
-
Events
Internal and external events Here you can find an overview of internal and external events. Among the internal events you can also find the courses and workshops of the QUEST Center. Courses and workshops that we offer regularly, but for which no date has been set yet, can be found here . Archiv Past Events
-
Oxford | Berlin Summer School
Data protection declaration of the BIH QUEST Center Data protection declaration of the BIH QUEST Center Download, Pdf (569 KB)
-
Press release In severe COVID-19 cases, neutrophils work around the clock
The course of SARS-CoV-2 coronavirus infections depends not only on how aggressive the virus is, but also on the immune response of the infected individual. Using single-cell analyses, a group of researchers led by Samantha Praktiknjo of the Berlin Institute of Health at Charité (BIH), Markus Landthaler of the Max Delbrück Center and Jakob Trimpert…
-
Press release New perspectives for patients: National Strategy for Gene and Cell Therapies presented to the BMBF
Today, the Berlin Institute of Health at Charité (BIH) officially handed over the National Strategy for Gene and Cell Therapies to Federal Research Minister Bettina Stark-Watzinger (FDP). Some 150 experts from various stakeholder groups drew up the paper and developed a road map for improving healthcare and strengthening Germany as a hub for gene…